The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPjsc Tatneft Regulatory News (ATAD)

  • This share is currently suspended. It was suspended at a price of 2.35

Share Price Information for Pjsc Tatneft (ATAD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.35
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.35
ATAD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

22 May 2015 18:28

RNS Number : 1237O
OAO Tatneft
22 May 2015
 



Notification on ownership of shares in Tatneft

 

22 May 2015

 

On 22 May 2015 OAO Tatneft ("Tatneft") made the following statutory disclosure in the Russian Federation about ownership of shares in Tatneft:

 

 

Name of person that acquired rights to voting shares:

Raiffeisen Bank International AG

Address:

Am Stadtpark 91030 ViennaAustria

Postal address:

Troitskaya Street 17

Building 1

Moscow, 129090,

Russia

Registration number:

FN122119m

Type of disposal (ownership) rights to voting shares:

Direct ownership; acting on its own account

Number of voting shares of Tatneft:

132 701 714 or 6.09%

Number of voting shares of Tatneft prior to the acquisition of rights to voting shares:

Not available

Date of acquiring the rights for voting shares:

8 May 2015

 

 

 

Forward-looking statements: These materials contain statements about future events and expectations that are forward-looking in nature. Any statement in these materials that is not a statement of historical fact is a forward-looking statement that involves known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to differ. OAO Tatneft assumes no obligations to update the forward-looking statements contained herein to reflect actual results, changes in assumptions or changes in factors affecting these statements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPKBDBOBKDPPB
Date   Source Headline
29th Dec 202311:41 amRNSEGM Approves Dividends for 9m 2023
21st Nov 20233:18 pmRNSTatneft EGM to approve 9m 2023 dividend
29th Sep 20239:42 amRNSTatneft EGM approves 6m 2023 dividend
15th Aug 20233:21 pmRNSBoard of Directors 1H 2023 div and EGM decisions
30th Jun 20232:44 pmRNSPJSC Tatneft AGM Results
19th Jun 20238:33 amRNSNotice of AGM
27th Apr 202312:20 pmRNSAGM Notice and Dividend Recommendation
30th Mar 20232:15 pmRNSAcquisition of business from Nokian Tyres plc
20th Mar 20237:00 amRNSTatneft's Annual IFRS and Directors' Report
28th Dec 20227:00 amRNSResult of EGM
16th Nov 20227:24 amRNSBoard Recommends Dividends for 9m2022
28th Oct 20224:16 pmRNSTatneft to acquire Russian assets of Nokian Tyres
23rd Sep 202210:09 amRNSTatneft EGM Approves Dividends for 1H2022
30th Aug 20227:00 amRNSTatneft publishes IFRS results for 1H2022
16th Aug 20229:52 amRNSBoard convenes EGM and recommends dividends 1H2022
9th Aug 202211:42 amRNSNew Legal Regime for ADR Holders
24th Jun 20224:35 pmRNSResult of AGM
15th Jun 20223:29 pmRNSPayments to Governments Report 2021
31st May 20229:45 amRNSStatement regarding 1Q 2022 IFRS accounts
23rd May 20222:40 pmRNSBoard Recommends Dividends
17th May 202210:32 amRNSTatneft Obtained Permit to Continue ADR Program
16th May 20228:46 amRNSTatneft Sells Tire Business
29th Apr 20222:04 pmRNSBoard Reapproves Nominations to the Board
27th Apr 202212:28 pmRNSNotice to ADR Holders
25th Apr 20225:24 pmRNSBoard Approves AGM Agenda, Related Issues
19th Apr 202211:10 amRNSLaw Affecting ADR Program - Correction
19th Apr 20229:22 amRNSLaw Affecting ADR Program
1st Apr 20223:10 pmRNSDraft Law; Rating Withdrawal
15th Mar 20228:31 amRNSAnnual Financial Report
14th Mar 202210:06 amRNSStatement regarding Ratings
10th Mar 20223:18 pmRNSBoard Approves Nominations
2nd Mar 20224:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:36 pmRNSPrice Monitoring Extension
1st Mar 20224:43 pmRNSSecond Price Monitoring Extn
1st Mar 20224:37 pmRNSPrice Monitoring Extension
28th Feb 20224:41 pmRNSSecond Price Monitoring Extn
28th Feb 20224:37 pmRNSPrice Monitoring Extension
30th Dec 20211:34 pmRNSResult of EGM - Dividends
20th Dec 20219:26 amRNSNew Committee of the Board
30th Nov 202112:35 pmRNSPresentation to Investors
29th Nov 20217:32 amRNS3rd Quarter Results
23rd Nov 20218:03 amRNSBoard Recommends 3Q Dividends
1st Oct 202110:05 amRNSDividend Declaration
27th Aug 20217:25 amRNSHalf-year Report
26th Aug 202110:19 amRNSBoard convenes EGM, recommends dividends
1st Jul 20217:00 amRNSFirst Board Meeting and Board Committees Election
30th Jun 20215:15 pmRNSPayments to Governments Report
25th Jun 20215:10 pmRNSResult of AGM
9th Jun 20212:37 pmRNSAcquisition of EkoPet
4th Jun 20217:30 amRNS1st Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.